These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

492 related articles for article (PubMed ID: 30120476)

  • 1. Effect of Cell-Free DNA Screening vs Direct Invasive Diagnosis on Miscarriage Rates in Women With Pregnancies at High Risk of Trisomy 21: A Randomized Clinical Trial.
    Malan V; Bussières L; Winer N; Jais JP; Baptiste A; Le Lorc'h M; Elie C; O'Gorman N; Fries N; Houfflin-Debarge V; Sentilhes L; Vekemans M; Ville Y; Salomon LJ;
    JAMA; 2018 Aug; 320(6):557-565. PubMed ID: 30120476
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Contingent first-trimester screening for aneuploidies with cell-free DNA in a Danish clinical setting.
    Miltoft CB; Rode L; Ekelund CK; Sundberg K; Kjaergaard S; Zingenberg H; Tabor A
    Ultrasound Obstet Gynecol; 2018 Apr; 51(4):470-479. PubMed ID: 28640470
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Routine first-trimester screening for fetal trisomies in twin pregnancy: cell-free DNA test contingent on results from combined test.
    Galeva S; Konstantinidou L; Gil MM; Akolekar R; Nicolaides KH
    Ultrasound Obstet Gynecol; 2019 Feb; 53(2):208-213. PubMed ID: 30353581
    [TBL] [Abstract][Full Text] [Related]  

  • 4. First-trimester risk assessment based on ultrasound and cell-free DNA vs combined screening: a randomized controlled trial.
    Kagan KO; Sroka F; Sonek J; Abele H; Lüthgens K; Schmid M; Wagner P; Brucker S; Wallwiener D; Hoopmann M
    Ultrasound Obstet Gynecol; 2018 Apr; 51(4):437-444. PubMed ID: 28925570
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Procedure-related risk of miscarriage following chorionic villus sampling and amniocentesis.
    Beta J; Zhang W; Geris S; Kostiv V; Akolekar R
    Ultrasound Obstet Gynecol; 2019 Oct; 54(4):452-457. PubMed ID: 30977213
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical implementation of routine screening for fetal trisomies in the UK NHS: cell-free DNA test contingent on results from first-trimester combined test.
    Gil MM; Revello R; Poon LC; Akolekar R; Nicolaides KH
    Ultrasound Obstet Gynecol; 2016 Jan; 47(1):45-52. PubMed ID: 26498918
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risk of miscarriage following amniocentesis or chorionic villus sampling: systematic review of literature and updated meta-analysis.
    Salomon LJ; Sotiriadis A; Wulff CB; Odibo A; Akolekar R
    Ultrasound Obstet Gynecol; 2019 Oct; 54(4):442-451. PubMed ID: 31124209
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Screening for trisomy 21 in twins using first trimester ultrasound and maternal serum biochemistry in a one-stop clinic: a review of three years experience.
    Spencer K; Nicolaides KH
    BJOG; 2003 Mar; 110(3):276-80. PubMed ID: 12628267
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [MODELS OF CLINICAL IMPLEMENTATION OF CELL FREE FETAL DNA IN THE MATERNAL SERUM SCREENING TEST-ANALYSIS].
    Yankova M; Chaveeva P; Stratieva V
    Akush Ginekol (Sofiia); 2015; 54(7):15-21. PubMed ID: 27025103
    [TBL] [Abstract][Full Text] [Related]  

  • 10. DNA sequencing versus standard prenatal aneuploidy screening.
    Bianchi DW; Parker RL; Wentworth J; Madankumar R; Saffer C; Das AF; Craig JA; Chudova DI; Devers PL; Jones KW; Oliver K; Rava RP; Sehnert AJ;
    N Engl J Med; 2014 Feb; 370(9):799-808. PubMed ID: 24571752
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Screening for trisomies by cfDNA testing of maternal blood in twin pregnancy: update of The Fetal Medicine Foundation results and meta-analysis.
    Gil MM; Galeva S; Jani J; Konstantinidou L; Akolekar R; Plana MN; Nicolaides KH
    Ultrasound Obstet Gynecol; 2019 Jun; 53(6):734-742. PubMed ID: 31165549
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cell-free fetal DNA analysis in maternal plasma as screening test for trisomies 21, 18 and 13 in twin pregnancy.
    Le Conte G; Letourneau A; Jani J; Kleinfinger P; Lohmann L; Costa JM; Benachi A
    Ultrasound Obstet Gynecol; 2018 Sep; 52(3):318-324. PubMed ID: 28833712
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prenatal diagnosis versus first-trimester screening of trisomy 21 among pregnant women aged 35 or more.
    Ghi T; Arcangeli T; Ravennati F; Salsi G; Montaguti E; Pacella G; Maroni E; Pittalis MC; Pompilii E; Pilu G; Rizzo N
    J Matern Fetal Neonatal Med; 2015 Apr; 28(6):674-8. PubMed ID: 24866349
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical application of a contingent screening strategy for trisomies with cell-free DNA: a pilot study.
    Sánchez-Durán MÁ; Bernabeu García A; Calero I; Ramis Fossas J; Illescas T; Avilés MT; Maiz N; Carreras E
    BMC Pregnancy Childbirth; 2019 Aug; 19(1):274. PubMed ID: 31370808
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Obstetrical Outcomes of Amniocentesis or Chorionic Villus Sampling in Dichorionic Twin Pregnancies.
    Kim MS; Moon MJ; Kang S; Jung SH; Chang SW; Ki HJ; Kim B; Ahn E
    J Korean Med Sci; 2019 May; 34(18):e142. PubMed ID: 31074255
    [TBL] [Abstract][Full Text] [Related]  

  • 16. New approach for estimating risk of miscarriage after chorionic villus sampling.
    Gil MM; Molina FS; Rodríguez-Fernández M; Delgado JL; Carrillo MP; Jani J; Plasencia W; Stratieva V; Maíz N; Carretero P; Lismonde A; Chaveeva P; Burgos J; Santacruz B; Zamora J; De Paco Matallana C
    Ultrasound Obstet Gynecol; 2020 Nov; 56(5):656-663. PubMed ID: 32281125
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Positive predictive value estimates for cell-free noninvasive prenatal screening from data of a large referral genetic diagnostic laboratory.
    Petersen AK; Cheung SW; Smith JL; Bi W; Ward PA; Peacock S; Braxton A; Van Den Veyver IB; Breman AM
    Am J Obstet Gynecol; 2017 Dec; 217(6):691.e1-691.e6. PubMed ID: 29032050
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Screening for trisomies by cell-free DNA testing of maternal blood: consequences of a failed result.
    Revello R; Sarno L; Ispas A; Akolekar R; Nicolaides KH
    Ultrasound Obstet Gynecol; 2016 Jun; 47(6):698-704. PubMed ID: 26743020
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rare autosomal trisomies: comparison of detection through cell-free DNA analysis and direct chromosome preparation of chorionic villus samples.
    Benn P; Malvestiti F; Grimi B; Maggi F; Simoni G; Grati FR
    Ultrasound Obstet Gynecol; 2019 Oct; 54(4):458-467. PubMed ID: 31237735
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Second-trimester amniocentesis vs. chorionic villus sampling for prenatal diagnosis in multiple gestations.
    Antsaklis A; Souka AP; Daskalakis G; Kavalakis Y; Michalas S
    Ultrasound Obstet Gynecol; 2002 Nov; 20(5):476-81. PubMed ID: 12423485
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.